Parkinson’s UK and the University of Sheffield have launched a groundbreaking ‘virtual biotech’ company to develop new treatments for Parkinson’s disease. To be called Keapstone ...
It was a big week for companies offering virtual nutrition services with Berry Street and Fay both receiving $50 million ...
The company’s disclosure falls under Item 7.01 – Regulation FD Disclosure in the Form 8-K filing. This section highlights the participation of Moleculin Biotech’s CEO in the virtual investor ...
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...
The Company initiated its second lung cancer ... and upcoming milestones in a fireside chat at BTIG’s Virtual Biotechnology Conference 2024. The conversation with Kaveri Pohlman, PhD, Director ...
Detailed price information for Alx Oncology Holdings Inc (ALXO-Q) from The Globe and Mail including charting and trades.
Moleculin Biotech, Inc, a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback